AI assistant
Sending…
Sarepta Therapeutics, Inc. — Director's Dealing 2012
Nov 8, 2012
31721_dirs_2012-11-07_3665ff5e-3168-4246-a5fa-0f6b2ddce84d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Sarepta Therapeutics, Inc. (SRPT)
CIK: 0000873303
Period of Report: 2012-11-05
Reporting Person: Howton David T (SVP, General Counsel)
More from Sarepta Therapeutics, Inc.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 6
Interim / Quarterly Report
2026
May 6
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Annual Report
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Proxy Solicitation & Information Statement
2026
Apr 24
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 4